BRIEF published on 03/16/2026 at 10:40, 3 months 19 days ago Piramal Pharma Solutions Achieves 1,500th ADC Batch Milestone Pharmaceutical Development Piramal Pharma Grangemouth Facility ADC Manufacturing Bioconjugate Therapies
PRESS RELEASE published on 03/16/2026 at 10:35, 3 months 19 days ago Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch Piramal Pharma Solutions' Grangemouth, UK Facility achieves 1,500th ADC batch milestone, showcasing advanced capabilities and commitment to bioconjugate therapies CDMO Piramal Pharma Solutions Grangemouth Bioconjugate Therapies ADC Batch
BRIEF published on 02/02/2026 at 17:15, 5 months 2 days ago Piramal Pharma Solutions Unveils Tablet-in-Capsule Technology Drug Delivery Piramal Pharma Tablet-in-Capsule Patient Centricity Customized Dosing
PRESS RELEASE published on 02/02/2026 at 17:10, 5 months 2 days ago Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities Piramal Pharma Solutions successfully develops tablet-in-capsule drug delivery system, offering flexible dosing options for oral therapies. Enhancing patient-centric solutions Drug Delivery System Patient-centric Piramal Pharma Solutions Tablet-in-Capsule Flexible Dosing Options
BRIEF published on 12/15/2025 at 07:10, 6 months 20 days ago Piramal Pharma Solutions Achieves High Net Promoter Score Operational Excellence Net Promoter Score Customer Loyalty Piramal Pharma Competitive Positioning
PRESS RELEASE published on 12/15/2025 at 07:05, 6 months 20 days ago Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score Piramal Pharma Solutions achieves impressive Net Promoter Score (NPS) of 55, surpassing industry averages, reflecting commitment to excellence and stakeholder centricity Operational Excellence Net Promoter Score Piramal Pharma Solutions NPS Stakeholder Centricity
BRIEF published on 11/26/2025 at 20:30, 7 months 8 days ago Piramal Pharma Solutions Ensures Compliance with Nitrosamine Regulations Regulatory Standards Piramal Pharma Solutions Nitrosamine Compliance Pharmaceutical Safety Testing Capabilities
PRESS RELEASE published on 11/26/2025 at 20:25, 7 months 8 days ago Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities Piramal Pharma Solutions achieves regulatory compliance for nitrosamine impurities, ensuring safety & adherence to global guidelines, enhancing capabilities & operational excellence Regulatory Compliance Operational Excellence Patient Safety Piramal Pharma Solutions Nitrosamine Impurities
BRIEF published on 11/19/2025 at 09:00, 7 months 15 days ago Piramal Pharma's Grangemouth Facility Secures Updated MHRA GMP Certifications ADC Development GMP Certification MHRA Approval Piramal Pharma Grangemouth Facility
PRESS RELEASE published on 11/19/2025 at 08:55, 7 months 15 days ago Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK receives updated MHRA GMP certificates, highlighting commitment to quality and regulatory excellence Drug Development Piramal Pharma Solutions Bioconjugates Facility MHRA GMP Certificates Grangemouth
Published on 07/03/2026 at 23:00, 1 day 4 hours ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 1 day 5 hours ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 1 day 7 hours ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 1 day 13 hours ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/04/2026 at 17:35, 9 hours 36 minutes ago Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 16 hours 9 minutes ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 18 hours 6 minutes ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 18:55, 1 day 8 hours ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 1 day 8 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/03/2026 at 21:49, 1 day 5 hours ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 1 day 8 hours ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 1 day 8 hours ago Disclosure of transactions in own shares from July 1 to July 3, 2026
Published on 07/03/2026 at 18:00, 1 day 9 hours ago Half-year liquidity contract statement June 30, 2026
Published on 07/03/2026 at 17:54, 1 day 9 hours ago Mersen: Number of shares and voting rights as of June 30, 2026
